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Background. In the acute rejection of allografts, the 
interaction between Fas (CD95) and its ligand (FasL; 
CD95L) has been shown to be involved in mediating 
apoptotic cell death. The role, however, of these mol-
ecules in the pathogenesis of transplant vascular scle-
rosis is as yet undetermined. The present study was 
therefore designed to address this issue. 
MateriaL C3HIHEJ FasUld (FasL -; H2k) spontane-
ously mutant mice were used either as donors or re-
cipients of aortic allografts; wild-type C57B1I6 (B6; 
H2b ) were used as corresponding recipients or donors 
(n=61group), respectively. Controls included aortas 
transplanted across appropriate allogeneic and synge-
neic strain combinations. For histopathological eval-
uations, the grafts were harvested at day 40 after 
transplantation, at which time, splenocytes and sera 
were also obtained for mixed leukocyte reaction and 
complement-mediated microcytotoxicity assays, re-
spectively. 
Results. Similar to aortas obtained from allogeneic 
controls, allografts harvested from FasL - -+ B6 recipi-
ents had morphological evidence of chronic rejection 
characterized by circumferential intimal thickening 
with partial disruption of the elastic membranes. Cor-
respondingly, heightened antidonor cellular reactiv-
ity was also witnessed in these recipients. On the con-
trary, B6 allografts harvested from the majority of 
C3H-+FasL - recipients exhibited marked preserva-
tion of aortic morphology. Although these recipients 
had diminished antidonor cellular proliferation, the 
titers of alloantibodies were markedly elevated. 
Conclusion. The presence of FasL-expressing func-
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tional cytotoxic T cells is required for the pathogene-
sis of transplant vascular sclerosis. The significant re-
duction and/or absence of chronic rejection with the 
concomitant retention of antidonor humoral response 
in C3H FasL- recipients of B6 aortas prompt us to 
suggest that perhaps posttransplantation vasculopa-
thy is initiated by cell-mediated cytotoxicity with its 
perpetuation facilitated by alloantibodies. 
At a molecular level. the acute rejection of allografts by 
activated cytotoxic T cells (CTLs*) has been shown to be 
mediated by two distinct pathways: the perf orin and gran-
zyme-induced lysis and the ligand-induced apoptosis (1). Of 
the latter, perhaps the most predominant interaction is that 
between Fas (Apo-! CD95) and its ligand (FasL; CD95L) (2. 
3). Fas. a type 1 membrane protein belonging to the tumor 
necrosis factor/nerve growth factor receptor family. has been 
documented to be ubiquitously expressed in various tissues 
of the body (4). On the contrary, expression of FasL, which is 
a type 2 membrane protein sharing significant homology 
with members of the tumor necrosis factor family, is more 
limited, being found primarily on activated T cells (5, 6) and 
cells of distinct phenotype in the testis (7) and in the eye (8). 
It has been postulated that FasL expressed on activated 
CTLs can induce apoptosis in Fas-expressing target tissue 
(4). The expression of CD95L or "death" factor on various 
CTL cell lines (9) and on activated splenocytes (10) has pro-
vided evidence to support the hypothesis that this molecule 
functions as an effector of CTL-mediated cytotoxicity. The 
presence of residual CTL in perf orin-deficient mice, which 
was known to be mediated by FasL (11, 12), corroborated 
unequivocally the earlier findings suggesting that the inter-
action between CD95-CD95L plays a cardinal role in allo-
graft destruction during acute cellular rejection (ACR). The 
role, however, of these molecules in the pathogenesis of 
* Abbreviations: a-smA, alpha smooth muscle actin; ACR, acute 
cellular rejection; B6, C57B1I6; CR, chronic rejection; CTL, cytotoxic 
T cells; FasL. Fas ligand; FasL -, C3HJHEJ-FasLllld; gld. generalized 
lymphoproliferative disease; Ipr. lymphoproliferation; TVS, trans-
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transplant vascular sclerosis (TVS) remains as yet undeter-
mined. 
In the lpr (lymphoproliferative) mouse, the expression of 
CD95 has been documented to be markedly reduced (13,14). 
On the contrary, in the gld (generalized lymphoproliferative 
disease) mouse, the ability of CD95L to bind to Fas was 
shown to be abolished (4). The latter outcome is believed to be 
the result of a point mutation in the C-terroinus of the coding 
region for FasL gene, which has been mapped to mouse 
chromosome 1 (15, 16). In an established model of TVS (17-
19), we have used mice bearing gld mutations as donors and 
recipients of aortic allografts to study the role of FasL in the 
pathogenesis ofthis lesion. This model also provided us with 
the unique opportunity to study the role of alloantibodies in 
the evolvement of obliterative arteriopathy. 
MATERIALS AND METHODS 
Animals. Seven- to B-week-old inbred male C3H/HEJ (H2k), C3H1 
HEJ-FasLgld (H2k; FasL -), C57BVS <H2b; BS), and BALBlc <H2d ) 
mice were purchased from The Jackson Laboratory (Bar Harbor, 
ME). Upon arrival in Pittsburgh, they were housed in a pathogen-
free facility and provided ad libitum with Purina rodent chow and 
tap water. For experiments detailed herewith, the mice were used at 
10-12 weeks of age. 
Aortic transplantation. The aorta was transplanted by a method 
detailed elsewhere (19). Using a dissecting microscope (M-32; Leica, 
Northvale, NJ) and under methoxyflurane (Metofane; Pitman-
Moore, Inc., Munderlein, IL)-induced anesthesia, a 0.6-cm section of 
donor thoracic aorta was transplanted end-to-side to the recipient 
abdominal aorta caudal to the origin of the renal arteries. It was 
subsequently converted into a "jump" graft by ligation and severance 
of recipient aorta between the anastomotic sites. 
Experimental groups. The aortic transplant recipients were di-
vided into the following groups: group I (syngeneic)=C3H-+C3H and 
B6-B6; group II (allogeneic)=C3H-+B6 and B6-+C3H; group 
III=C3H FasL - -B6; and group IV=B6-+C3H FasL -. After trans-
plantation, the recipients did not receive any immunosuppressive 
therapy. It is noteworthy that at the time of transplantation, the 
FasL - animals had no clinical evidence of gld, whereas the presence 
of mild-moderate lymphadenopathy was routinely encountered in 
these recipients at the time of aortic harvest (day 40 after transplan-
tation). 
Histological examination. At 40 days after transplantation, the 
implanted aorta was harvested en bloc and fIxed by placing in 10% 
neutral buffered formalin (VWR, Cleveland, OR) for 48-72 hr fol-
lowed by routine processing and embedding into paraffin (Sherwood 
Medical. St. Louis, MO). Sections (4 J.lm thick) were obtained and 
mounted onto precleaned slides. These sections were used for routine 
hematoxylin and eosin (Surgipath, Richmond, IL) staining and for 
elastic fibers (Verhoeff-van-Gieson's: VVG) (20), collagen (Mason's 
trichrome) (20), and alpha smooth muscle actin (a-smA) (21). 
Morphometry. To provide a more objective assessment of the de-
gree of intimal thickening, we resorted to undertaking morphometric 
evaluation in all transplanted aortas harvested at day 40 after trans-
plantation. For this purpose, a morphometric graticle was used. and 
the degree of intimal thickening was ascertained under x40 magni· 
fication. Using light microscopy, two-four sections of aorta harvested 
from each animal (n=4-5 animals/group) were analyzed; at a min-
imum. 10 measurements were obtained from each aorta. For primary 
analysis. VVG-stained sections were used: however. these findings 
were confirmed by concurrent evaluation of hematoxylin and eosin 
and ,,·smA-stained sections. The results were expressed as microns 
(J.l; mean::!: SEl. For statistical analysis. a multiple intergroup com-
parisons lBonferrom) test was used with significance being defined 
as sO.05. 
Mixed leukocyte reaction. At the time of death (day 40 after trans-
plantation), the recipient spleen was also harvested and processed to 
yield splenocytes. Untreated nylon wool-enriched T cells were used 
as responders (5 x 105 cells/well) to an equivalent number of y-irra-
diated (-3Gy; Cesium137; GammacelllOOO, MDS Nordion, Ontario, 
Canada) stimulators obtained from the splenocytes of either the 
donor or third-party animals. The cells were placed in triplicate in a 
96-well round-bottomed microtiter plate and incubated in 5% CO2 in 
air. Seventy-two hours later, the cells were pulsed with 1 J.lCi of 
]3H[thymidine (NEN Dupont, Beverly, MA) and incubated for an 
additional 16-18 hr until harvesting. The degree of [3H1thymidine 
incorporation was measured by scintillation counting, and the re-
sults were expressed as counts per minute (cpm; mean ± SD). Re-
sponders or y-irradiated stimulators cultured in media were used as 
controls. Because T cell-mediated cytolytic activity is known to be 
deficient in FasL - recipients (1, 10-12), these assays were not per-
formed in this study. 
Complement-dependent microcytotoxicity. Recipient serum ob-
tained at the time of death was used to measure the titer of alloan-
tibodies. 'Syngeneic and allogeneic (donor and third-party) spleno-
cytes were suspended at 2x106 cells/ml; 2 /Jol (4X102 cells) of which 
was incubated in Terasaki microplates with an equivalent volume of 
decomplemented sera for 30 min at RT. To ascertain the titers of 
alloantibodies, the sera were used at varying known dilutions. At the 
end of this incubation, the cells were washed three times with phos-
phate-buffered saline, and 21J.i (1/10 dilution) of pretested, nontoxic, 
guinea pig complement (Cedarlane Labs LTD, Hornby, Ontario, 
Canada) was added for 20 min at 37°C in 5% CO2 in air. To terminate 
further complement-mediated lysis, the plates were placed at 4°C for 
5 minutes. The viability of the cells was assessed by dye exclusion, 
which was performed by adding 2 /Jol of 2% eosin (wlv) for 10 min. 
Viability was determined by enumerating live and dead cells in each 
well using an inverted phase-contrast microscope. The formula used 
to calculate cytotoxicity was as follows: 
cytotoxicity index 
(% cells dead with C+serum)-(% cell dead with C) --------~1~M~M--~E~~o-c-el~b-d~e~a~d~w-l~th~C~F==~==~u1MM 
RESULTS 
Histopathological and immunohistochemical analysis. As 
described previously (17-19), aortic grafts transplanted 
across syngeneic (group I; B6-+B6 or C3H-+C3H) animals 
exhibited normal aortic morphology when harvested at day 
40 after transplantation. There was no obvious denudation of 
the single-cell endothelial lining, and the elastic limiting 
membranes were also well preserved (Fig. IA). Unlike that in 
the media, no a-smA + staining was visualized in the intima 
(Fig. 1Bl-a finding reminiscent of that observed in the na-
tive aortas. 
On the contrary, aortic allografts harvested at day 40 after 
transplantation from recipients in group II (C3H-+B6 or 
B6 ..... C3H) had morphological aberrations considered patho-
gnomonic of chronic rejection (CRl (Fig. IC). There was cir-
cumferential intimal thickening (Fig. 2), which was largely 
due to accumulation and/or proliferation of a-smA + cells (Fig. 
10). This resulted in narrowing of the lumen, which we had 
shown previously to be a progressively worsening event in 
aortas transplanted across these allogeneic strain combina-
tions l17-19). It must be emphasized that the histopatholog-
ical changes detailed heretofore were comparable in aortas 
transplanted across both C3H--B6 and B6-+C3H strain 
combinations. 
Similar to grafts harvested from allogeneic strain combi-
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FIGURE 1. Histoimmunopathological evaluation of the morphology of aorta obtained at day 40 after transplantation. The sections were 
stained either with WG (A, C, E, and G) or {t-smAantibody (B, D. F. and Hl. Grafts were harvested from either 86-86 (A and Bl: B6-C3H 
(C and O): C3H FasL --B6 (E and F); or B6-C3H FasL - (Q and F) recipients. Original magnification: x 100 (A. C, E. and 0); x400 (B, D. 
F, and Hl. 
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FIGURE 2. Morphometric analysis of the degree of intimal thicken-
ing in aortic allografts harvested at day 40 after transplantation. For 
primary analysis, WG-stained sections were used, however, these 
findings were confirmed by concurrent evaluation of hematoxylin 
and eosin and a-smA-stained sections. Grafts were harvested from 
either B6--+C3H (.); C3H-- B6 (D); C3H FasL - --B6 (D); or 
B6--+C3H FasL - E~F recipients. Intimal thickening was measured 
using morphometric graticle at x40 magnification (light microsco-
py). Ten measurements of each aorta (two to four sections/aortal 
animal) were obtained (n=4-5 animals/group) for this analysis. Re-
sults are expressed as mean :!: SE (I.d. 
nations (group Il), aortas transplanted across C3H 
FasL - --<- B6 (group IIl) mice also had comparable intimal 
changes when examined at day 40 after transplantation 
(Figs. IE and 2). There was circumferential intimal thicken-
ing (Fig. 2) with destruction of the endothelium and the 
elastic membranes. Furthermore, as in the untreated allo-
grafts (Fig. 1m, the observed aberration in intimal morphol-
ogy was largely due to proliferation of a-smA + cells (Fig. IF). 
Contrarily, in the majority of recipients. the histology of B6 
aortic allografts harvested from C3H FasL - animals was 
remarkably preserved (Figs. IG, IH, and 2). There was no 
evidence of circumferential intimal thickening (Fig. 2), and 
the staining for a-smA + cells was largely limited to the media 
(Fig. IH). These observations were very similar to those 
encountered in native aorta as well as in grafts transplanted 
across syngeneic barriers (Fig. 1, A and 8). It is noteworthy 
that similar observations were made in aortas harvested at 
days 70-80 after transplantation from FasL - recipients of 
B6 allografts (data not shown). 
Mixed leukocyte reaction. As anticipated, nylon wool-en-
riched T cells obtained 30-40 days after transplantation 
from C3H recipients of B6 allografts proliferated against 
both donor and third-party (BALB/c) irradiated stimulators 
(Table 1). Similar observations were also made when re-
sponders were obtained from B6 recipients of C3H aortic 
allografts. Inversely, [3H]thymidine uptake was relatively 
lower when responders were cultured in media alone or with 
syngeneic stimulators (Table 1). Analogous observations 
were also made when splenocytes from B6 recipients of C3H 
FasL - aortas were used as responders. Interestingly, in 
these recipients, the heightened donor and the third-party 
specific alloreactivity was associated with distinct morpho-
logical aberration in the transplanted allografts (Fig. 1, B 
and C), suggesting that cellular responses playa seminal role 
in the pathogenesis of CR. On the contrary, markedly re-
duced antidonor reactivity was witnessed in C3H FasL-
recipients of B6, who otherwise responded adequately to 
third-party stimulators (Table 1). Incidentally, aortic allo-
grafts harvested from the majority of these animals had 
significant reduction in changes pathognomonic of CR, fur-
ther corroborating our earlier contention that cell-mediated 
immune responses play a critical role in the initiation and 
perhaps perpetuation of this lesion. 
Complement-dependent microcytotoxicity. Decomplemented 
sera obtained at days 30-40 after transplantation from either 
B6 or C3H recipients of syngeneic aortas (group l) exhibited no 
humoral responses against C3H or B6 targets, respectively (Fig. 
3A). This finding was in contrast to that observed in sera of 
allograft recipients (group II), in whom markedly amplified 
antidonor cytotoxicity was evident. Similarly, sera from ani-
mals in groups III and IV also had elevated titers of anti donor 
antibodies (Fig. 3Bl. 
DISCUSSION 
The use of Fas-FasL by activated CD4 + and CD8 + T (11) 
and natural killer cells (22) is believed to be one of the 
predominant effector mechanisms used by these cells to me-
diate cytotoxicity. These molecules are also involved in the 
establishment and maintenance of peripheral tolerance (23) 
and in the activation-induced apoptosis of mature lympho-
cytes (24). These pleiotropic functions of Fas-FasL are per-
haps best exemplified in mice bearing either Fas ([pr) or 
FasL (gld) mutations in which failure to maintain immune 
homeostasis results in widespread lymphoproliferation, 
lymphadenopathy, lack of cytolytic activity, and production 
of high titers of autoreactive IgG and IgM antibodies with 
associated autoimmune disorders (16, 25, 26). 
The constitutive expression of FasL on Sertoli cells of the 
testis and on tissues of the anterior chamber of the eye has 
TABLE 1. Results of mixed leukocyte reaction using 5x 105 splenocyteslwell as stimulators tirradiated) or responders 
Irradiated stimulators 
Responders 
Media Donor Recipient Third party 
B6-C3H 1405:!:754 8815:::1544 1553:::242 19682:::4555 
C3H ...... B6 1564:::186 18986:::1686 1556:::535 19836:::3366 
C3H FasL -~BS 1996:::831 14075:::991 3675:::312 74232:::11055 
B6--('3H FasL- 1617:::297 4615:::464 1575:::376 22692:::928 
Splenocytes obtained from aonic recipients at day 40 after transplantation were used as responders. The results are expressed as cpm 
\', ::SDl. 
-----,----_._-,.,----- -_ .. _---- K-K~-K---- .. -
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FIGURE 3. To determine the titers of alloantibodies, microcytotoxic-
ity assays were performed using decomplemented sera obtained from 
recipients at days 30-40 after aortic transplantation. The trans-
planted groups (n=5 animals/group) were as follows: lAl B6-+ B6; (2:.) 
C3H-C3H; (0) B6-C3H; (0) C3H-B6; (e) B6-C3H FasL - and 
(.) C3H FasL - -+ B6. The results (from triplicate wells) are ex-
pressed as mean:!: SD of antidonor cytotoxicity in (Al control and (B) 
study groups. 
underscored its participation in maintaining an immune 
privilege state at these sites (7, 8, 27). This assertion has 
been confirmed in a murine model of islet allotransplanta-
tion, whereby coimplantation of FasL-transfected syngeneic 
myoblasts resulted in prolonged islet allograft survival (2). 
Similarly, significantly delayed rejection of orthotopically 
transplanted corneal allografts obtained from FasL + but not 
FasL - mice provided yet further evidence for the seminal 
role played by this molecule in mediating graft destruction 
(3). Using a murine model of heterotopic heart transplanta-
tion, Larsen et al. (28) have provided contrary evidence sug-
gesting that the Fas-FasL pathway is not essential for medi-
ating efficient allograft rejection. However, in light of the 
documented observations, this latter conclusion is difficult to 
interpret. 
The multifactorial etiopathology of TVS has precluded a 
more comprehensive understanding of the mechanism(s) in-
volved in the pathogenesis of this lesion (29). However, de-
spite these limitations, the observed correlation of the sever-
ity of obliterative arteriosclerosis to the intensity and the 
frequency of ACR has underscored the importance of alloim-
mune responses in its evolvement (18, 19, 30). Despite the 
heretofore stipulated involvement of Fas-FasL in mediating 
tissue destruction in ACR, its role in the evolvement of TVS 
is as yet ambiguous. To delineate the role of FasL in the 
pathogenesis of TVS, we used FasL - mice as donors or re-
cipients of aortic grafts transplanted heterotopic ally across 
untreated wild-type allogeneic animals. 
As has been reported previously (17-19), aortic transplan-
tation across allogeneic but not syngeneic barriers resulted. 
by days 30-40 after implantation. in morphological changes 
distinctive of progressively worsening CR. There was evi-
dence of circumferential intimal thickening, destruction of 
the elastic membranes. and accumulation and/or prolifera-
tion of a-smA ~ cells exclusively within the intima. These 
animals also exhibited heightened antidonor proliferative 
activity confirming the importance of cellular immunity in 
the pathogenesis of CR. 
The role of alloantibodies in the development of TVS has 
also been widely premised (31-33). In cardiac transplant 
recipients, ongoing graft arteriosclerosis has been correlated 
with the presence of antidonor HLA antibodies (34). Addi-
tionally, Mohanakumar et al. (35) have demonstrated the 
presence of immunoglobulin and complement complexes 
within the loci of thickened intima in renal allograft recipi-
ents in whom late graft rejection was correlated with presen-
sitization to donor HLA-DR antigens. Perhaps a more con-
vincing evidence for the role of alloantibodies in the 
evolvement of this lesion was provided by studies in which 
histological aberrations pathognomonic of posttransplant 
vasculopathy were successfully reproduced by intra-arterial 
infusion of antidonor sera (36). 
To ascertain the role of alloantibodies in the pathogenesis 
of CR in this model, we also determined their titer using 
microcytotoxicity assays. The sera were obtained from recip-
ients of both syngeneic and allogeneic aortic transplants at 
day 40 after implantation, at a time when changes charac-
teristic of CR are most discernible (18). Unlike that in syn-
geneic combinations, markedly elevated titers of antidonor 
antibodies were detected in the sera of allogeneic recipients. 
This finding affirmed earlier observations (31-36) that in 
addition to antidonor cellular responses, alloantibodies may 
also play an important role in the development of CR. Still 
obscure, however, is the precise involvement of the cellular 
and humoral pathways in the initiation and/or perpetuation 
ofTVS. 
To a~ the role of FasL in the development of CR, 
aortas were transplanted from C3H FasL - mutant mice into 
wild-type allogeneic CBS) recipients. Interestingly, when har-
vested at days 30-40 after implantation, the morphological 
changes in the majority of these allografts were indiscernible 
from those in the untreated allogeneic ECPe~BpF controls. It 
is noteworthy that similar observations were also made in 
aortas harvested at days 70-80 after transplantation from 
FasL - recipients ofBS allografts (data not shown); this find-
ing precludes the argument that the observed preservation of 
morphology in the majority of these allografts reflects a mere 
alteration of the tempo of CR. Additionally, similar to allo-
geneic but not syngeneic controls, these recipients also ex-
hibited heightened antidonor cellular and humoral reactiv-
ity. It must be emphasized that these were anticipated 
observations because unlike Fas, FasL expression is known 
to be limited to activated T cells (5, 6) and to distinct im-
mune-privileged sites in the eye (8) and the testis (7). 
The outcome in allografts transplanted across BS~CPe 
FasL - mice, however, was quite different. When harvested at 
day 40 after transplantation. a majority of these allografts 
exhibited a marked reduction in changes characteristic of 
CR; their morphology was very similar to that of native aorta 
as well as to grafts implanted across syngeneic barriers. 
Initially, this observation seemed inexplicable given that el-
evated antidonor humoral responses were noted in these 
recipients. However. the subsequent demonstration in these 
recipients of reduced antidonor cellular reactivity suggested 
that perhaps the initiation of morphological aberrations 
characteristic of CR is initiated by cell-mediated cytotoxicity, 
with its perpetuation being facilitated by alloantibodies. 
In light of these foregoing observations. it is perhaps ratio-
nal to propose that the absence of a functional FasL on 
effector T cells results in a blunted cellular response with the 
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observed partial or complete freedom from changes patho-
gnomonic of posttransplant vasculopathy. Additionally, in 
the absence of an effective cell-mediated cytotoxicity, the 
presence of high titers of alloantibodies is incapable of initi-
ating and/or perpetuating histopathological changes of CR. 
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